pharmaphorum

JULY 7, 2022

Pfizer is still waiting for the green light to complete an acquisition of digital health company ResApp, a deal that looks even better now that its smartphone app for people with obstructive sleep apnoea (OSA) has been approved by the FDA. The post ResApp bags FDA okay for sleep apnoea app, after Pfizer takeover bid appeared first on.

FDA 105

FDA Prescription Healthcare Provider Patients 105

pharmaphorum

SEPTEMBER 1, 2022

Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available to patients and provides access to COVID-19 therapeutics that may otherwise be difficult to obtain. “We are currently focused on offering a convenient way to get prescriptions. The platform.

Medical 98

Medical Prescription Doctors Physicians 98

Legacy MEDSearch

JUNE 20, 2023

Food and Drug Administration (“FDA”) of BabySat , the first medical pulse-oximetry device featuring its advanced, wire-free sock design. BabySat is a step forward in solving some of these exact challenges by bringing real-time medical grade infant monitoring into the home, while under the supervision of a physician. Are you hiring?

Prescription 52

Prescription FDA Food and Drug Administration Recruitment 52

Pharmaceutical Technology

JULY 20, 2022

On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. .

Food and Drug Administration 111

Food and Drug Administration Physicians Medical Prescription 111

Pharma Marketing Network

FEBRUARY 17, 2025

Conferences and symposiums, too, are prime avenues to present research and engage with prescribing physicians. Full-page ads with clinical data can drive prescriptions. Here are key methods: Sales Uplift Analysis: Track prescription trends after ad campaigns. A spike in Trulicity prescriptions followed their TV ad blitz.

Pharma 52

Pharma Prescription Marketing Medical 52

Pharmaceutical Technology

MAY 5, 2023

The US Food and Drug Administration (FDA) has accepted Optinose’s supplemental new drug application (sNDA) for Xhance (fluticasone propionate) to treat chronic rhinosinusitis, which is now under review. The regulator has set 16 December 2023 as a prescription drug user fee act (PDUFA) target goal date.

Food and Drug Administration 52

Food and Drug Administration FDA Physicians Prescription 52

Pharma Marketing Network

MARCH 6, 2025

HCP Targeting Platforms like LinkedIn and Twitter allow brands to target physicians, pharmacists, and medical professionals based on specialty and location. Follow FDA and HIPAA Guidelines No misleading claims Every medical statement must be backed by FDA-approved data. Promote webinars and thought leadership content.

Media 52

Media Pharma Education Networking 52

Legacy MEDSearch

MARCH 15, 2023

The acquisition extends HeartBeam’s reach in remote monitoring and detection with full ownership of an existing cutting-edge FDA-cleared product. Founded in 2016, LIVMOR developed the Halo+ Atrial Fibrillation (AF) Detection System, the world’s first FDA-cleared prescription wearable for continuous cardiac rhythm monitoring.

Food and Drug Administration 97

Food and Drug Administration FDA Recruitment Physicians 97

PM360

AUGUST 9, 2022

The combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions by integrating Levrx’s plan-specific and real-time prescription insights into the Adhere Platform medication optimization offerings. The Andaman7 Platform Solution. Patient Adherence System.

Prescription 105

Prescription Medical Patients Side effects 105

Pharmaceutical Technology

JUNE 14, 2023

Ipsen has received US Food and Drug Administration (FDA) approval for Bylvay (odevixibat) to treat patients aged 12 months and above with cholestatic pruritus caused by Alagille syndrome (ALGS). The therapy is being offered immediately through prescription for eligible ALGS patients.

Food and Drug Administration 52

Food and Drug Administration FDA Transportation Prescription 52

Pharma Marketing Network

MARCH 13, 2025

Predict physician prescribing patterns to optimize sales outreach. Optimize inventory management based on prescription trends. FDA guidelines on AI-generated content. Can AI help with FDA compliance in pharma marketing? For example, AI can: Analyze patient data to recommend relevant treatments.

Marketing 52

Marketing Pharma Medical Ethics 52

PM360

AUGUST 9, 2022

According to a 2021 study by Statista, 40% of prescriptions written in 2005 were for brand-name medications. 1 How is this possible, given that more than 20,000 prescription drugs are currently in circulation in the U.S. 2 and over a million actively licensed physicians 3 are available to prescribe them? References: 1.

Prescription 52

Prescription Doctors Specialization Physicians 52

Clarivate

JULY 5, 2023

The month of July could see seven FDA-approved adalimumab biosimilars launch in the United States, an unprecedented situation for a market that has been relatively slow to embrace biosimilars. biologics market and reduce prescription drug costs. biologics market and reduce prescription drug costs.

Marketing 97

Marketing Physicians Manufacturing Competition 97

Pharmaceutical Technology

SEPTEMBER 23, 2022

Current treatment options for DES are dominated by a mix of prescription and over-the-counter (OTC) products. Artificial tears are also used extensively in conjunction with prescription therapies for symptomatic relief. Novaliq/ Bausch + Lomb’s NOV-3 (perfluorohexyloctane) is also currently at pre-registration stage with the FDA.

Prescription 59

Prescription Physicians FDA Marketing 59

pharmaphorum

DECEMBER 22, 2022

Prediction 1: the FDA will become more directive and collaborative on guidelines for DCTs. The risk of not having these discussions is to conduct expensive trials only to discover too late that they were measuring the wrong endpoint, in the wrong way, or with a tool or technology the FDA does not accept.

FDA 97

FDA Patients Electronics Medical 97

pharmaphorum

AUGUST 11, 2022

More than 60 percent of all American adults take prescription drugs , amounting to approximately 131 million individuals. Many FDA-cleared drugs have pharmacogenomics data on the label, which indicate the biomarker information to help guide decisions regarding the use of the therapeutic in individual patients.

Side effects 98

Side effects Medical Prescription Patients 98

Pharma Marketing Network

MARCH 3, 2025

With physicians spending more time online and patients searching for medical information, pharma marketers must refine their digital strategies to create meaningful engagement. Physicians are spending more time on digital platforms, while patients increasingly turn to the internet for healthcare information.

Pharma 52

Pharma Patients Physicians Doctors 52

Pharma Marketing Network

MARCH 3, 2025

With physicians spending more time online and patients searching for medical information, pharma marketers must refine their digital strategies to create meaningful engagement. Physicians are spending more time on digital platforms, while patients increasingly turn to the internet for healthcare information.

Pharma 52

Pharma Patients Physicians Doctors 52

Legacy MEDSearch

JUNE 15, 2023

Cala , the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced the commercial launch of its next generation system: the Cala kIQ System, the first and only FDA-cleared wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor and Parkinson’s disease.

Patients 98

Patients Recruitment Management Pharmacology 98

European Pharmaceutical Review

NOVEMBER 8, 2022

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. Citizen Petitions before the FDA. 2 Submission of a Citizen Petition to the FDA obligates the regulator to address the arguments raised. 5) monitoring access to biosimilars. Senate Bill 562 (S.

Food and Drug Administration 52

Food and Drug Administration Pharma Manufacturing Prescription 52

Pharmaceutical Technology

OCTOBER 25, 2022

Pharmaceutical companies – and the FDA – are embracing FDCs. From 1990 through 2013, the FDA approved 131 FDC products, on average 5.7 From 1990 through 2013, the FDA approved 131 FDC products, on average 5.7 Between 2010 and the end of 2015, of the 655 New Drug Applications (NDAs) approved by the FDA, 63 were for FDCs.

Manufacturing 52

Manufacturing Physicians Prescription Pharmaceutical 52

Clarify Health

MAY 19, 2020

After FDA-approval comes the last critical mile of this journey: bringing the product to market. Customer conversion and product uptake have largely depended upon live interactions between treating physicians and biopharma representatives (e.g., Which physicians see these patients? sales, medical science liaisons, etc.).

Biopharma 52

Biopharma Physicians Marketing Patients 52

Pharmaceutical Technology

DECEMBER 4, 2022

There are seven FDA-approved Humira biosimilars, of which Amgen’s Amjevita will be launched in January. Biosimilars with this designation are beneficial to payers as they eliminate the need for another prescription, she explains An interchangeable biosimilar can be automatically substituted for Humira at a pharmacy, Bhat adds.

Marketing 104

Marketing Physicians Competition Patients 104

Pharmaceutical Representative Training

JANUARY 29, 2025

While biologics only account for 2% of overall prescriptions, they contribute to 37% of net drug spending [1]. Biosimilars are biologic formulations that are very similar to a reference biologic product already approved by the FDA. The Cost-Saving Alternative: What are Biosimilars?

Marketing 52

Marketing Healthcare Healthcare Physicians 52

Pharma Marketing Network

MARCH 3, 2025

By refining user experience, messaging, and engagement strategies, pharma companies can increase prescription intent, patient adherence, and HCP interaction rates. Key Strategy: Use behavioral targeting to show customized drug information for cardiologists, neurologists, and primary care physicians instead of a generic homepage experience.

Pharma 52

Pharma Patients Prescription Medical 52

Pharmaceutical Representative Training

DECEMBER 28, 2021

Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines. The technology identifies.

Marketing 52

Marketing Food and Drug Administration Pharma Doctors 52

pharmaphorum

DECEMBER 15, 2022

Wise is also working on different versions of the software that will be developed as prescription DTx, with the objective of securing FDA approvals. “With this partnership, we aim to help patients combat mental health issues and make the process seamless for clinicians,” he added.

Education 52

Education Electronics Prescription Physicians 52

Pharma Marketing Network

FEBRUARY 27, 2025

The ability to target based on demographics, interests, location, and behavior makes PPC a game-changer for pharma brands promoting prescription drugs, disease awareness, and patient education resources. Compliance-Ready Ad Strategies Pharma PPC campaigns must comply with FDA, HIPAA, and Googles healthcare advertising policies.

Pharma 52

Pharma Marketing Networking Prescription 52

Pharma Marketing Network

JANUARY 29, 2025

A great example is how Merck and AstraZeneca use AI-driven content to engage physicians via targeted LinkedIn campaigns, automated email sequences, and interactive medical webinars. For instance, TikTok influencers promoting prescription drugs without proper disclosures have raised regulatory concerns.

Marketing 52

Marketing Pharma Pharmaceutical Ethics 52

Nixon Gwilt Law

JANUARY 16, 2024

Companies will also need to understand whether the FDA will consider their model to be software as a medical device (SaMD) that is subject to the FD&C Act. Rebecca says, “ New and existing companies will offer GLP-1 prescriptions for weight loss. We wrote about new Medicare coverage for emerging DTx technologies here.

Healthcare 52

Healthcare Healthcare Management Insurance 52

Nixon Gwilt Law

JANUARY 16, 2024

Companies will also need to understand whether the FDA will consider their model to be software as a medical device (SaMD) that is subject to the FD&C Act. Rebecca says, “ New and existing companies will offer GLP-1 prescriptions for weight loss. We wrote about new Medicare coverage for emerging DTx technologies here.

Healthcare 52

Healthcare Healthcare Management Insurance 52

World of DTC Marketing

JANUARY 1, 2022

1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. People don’t want to lose weight through diet and exercise if they can lose it through a prescription drug.

Healthcare 244

Healthcare Healthcare Side effects Prescription 244

Evolve Your Success

OCTOBER 3, 2023

Veronica discusses a revolutionary technology for testing and how it’s transforming the way physicians and patients approach cancer treatment. As the episode unfolds, Veronica talks about the future of diagnostic testing, where it’s headed, and the potential it holds for patients and physicians alike.

Sales 162

Sales Medical sales Physicians Patients 162

Pharmaceutical Technology

OCTOBER 1, 2022

The US Food and Drug Administration (FDA) has granted approval for Amylyx Pharmaceuticals’ Relyvrio (sodium phenylbutyrate and taurursodiol) to treat adult patients with amyotrophic lateral sclerosis (ALS). The FDA approval is based on findings from the multicentre Phase II CENTAUR clinical trial that enrolled 137 ALS patients.

Food and Drug Administration 97

Food and Drug Administration FDA Prescription Medicine 97

World of DTC Marketing

JULY 5, 2022

Pharma websites provide the prescription that can help people overcome health problems but too often, they ignore the patient’s responsibility to lose weight and exercise. The FDA should require every pharma product website to devote part of its content to prevention and the importance of exercise.

Insurance 200

Insurance Doctors Pharma Side effects 200

Pharmaceutical Technology

AUGUST 12, 2022

In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research. The FDA’s action plan. Thus, FDA funding could be what is needed on this front, says Cudkowicz.

FDA 98

FDA Food and Drug Administration Physicians Side effects 98

World of DTC Marketing

SEPTEMBER 22, 2021

Visting my doctor for my annual physical, I noticed huge LCD screens in each exam room with rotating ads for everything from prescription drugs to vitamins. Second, do people trust the FDA? ” 2wo: Physicians are still the gatekeepers of new Rx’s. First, there is confusion over treatments around COVID.

Doctors 43

Doctors Media Marketing Prescription 43